Elevance Health Inc
NYSE:ELV

Watchlist Manager
Elevance Health Inc Logo
Elevance Health Inc
NYSE:ELV
Watchlist
Price: 407.99 USD -0.71%
Market Cap: 94.6B USD
Have any thoughts about
Elevance Health Inc?
Write Note

Wall Street
Price Targets

ELV Price Targets Summary
Elevance Health Inc

Wall Street analysts forecast ELV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELV is 563.11 USD with a low forecast of 469.65 USD and a high forecast of 698.25 USD.

Lowest
Price Target
469.65 USD
15% Upside
Average
Price Target
563.11 USD
38% Upside
Highest
Price Target
698.25 USD
71% Upside

ELV Last Price Targets
Elevance Health Inc

The latest public price target was made on Oct 21, 2024 by David Windley from Jefferies , who expects ELV stock to rise by 30% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
David Windley
Jefferies
529 USD
Upside 30%
3 weeks ago
Oct 21, 2024
Elevance (ELV) PT Lowered to $529 at Jefferies
StreetInsider
Whit Mayo
Leerink Partners
515 USD
Upside 26%
3 weeks ago
Oct 21, 2024
Elevance (ELV) PT Lowered to $515 at Leerink Partners
StreetInsider
Ben Hendrix
RBC Capital
478 USD
Upside 17%
3 weeks ago
Oct 18, 2024
Elevance (ELV) PT Lowered to $478 at RBC Capital
StreetInsider
David MacDonald
Truist Financial
520 USD
Upside 27%
3 weeks ago
Oct 18, 2024
Elevance (ELV) PT Lowered to $520 at Truist Securities
StreetInsider
Sarah James
Raymond James
485 USD
Upside 19%
3 weeks ago
Oct 18, 2024
These Analysts Cut Their Forecasts On Elevance Health Following Q3 Earnings
Benzinga
Michael Ha
Robert W. Baird
625 USD
Upside 53%
4 weeks ago
Oct 16, 2024
Baird Reiterates Outperform Rating on Elevance (ELV)
StreetInsider
Ben Hendrix
RBC Capital
585 USD
Upside 43%
3 months ago
Jul 18, 2024
Elevance Health price target raised to $585 from $575 at RBC Capital
TheFly
David MacDonald
Truist Financial
620 USD
Upside 52%
3 months ago
Jul 15, 2024
Elevance Health price target raised to $620 from $600 at Truist
TheFly
Erin Wright
Morgan Stanley
643 USD
Upside 58%
4 months ago
Jun 24, 2024
Elevance Health initiated with an Overweight at Morgan Stanley
TheFly
Michael Ha
Robert W. Baird
649 USD
Upside 59%
5 months ago
May 29, 2024
Elevance Health initiated with an Outperform at Baird
TheFly
David Windley
Jefferies
604 USD
Upside 48%
6 months ago
Apr 19, 2024
Elevance (ELV) PT Raised to $604 at Jefferies
StreetInsider
Stephen Baxter
Wells Fargo
600 USD
Upside 47%
6 months ago
Apr 19, 2024
Elevance (ELV) PT Raised to $600 at Wells Fargo
StreetInsider
Ben Hendrix
RBC Capital
575 USD
Upside 41%
6 months ago
Apr 19, 2024
Elevance (ELV) PT Raised to $575 at RBC Capital
StreetInsider
Andrew Mok
Barclays
621 USD
Upside 52%
6 months ago
Apr 19, 2024
Elevance Health price target raised to $621 from $584 at Barclays
TheFly
AJ Rice
UBS
605 USD
Upside 48%
6 months ago
Apr 19, 2024
Elevance (ELV) PT Raised to $605 at UBS
StreetInsider
Show More Price Targets
Show Less Price Targets
David Windley
Jefferies
Price Target 529 USD
Upside/Downside 30%
View Source
Whit Mayo
Leerink Partners
Price Target 515 USD
Upside/Downside 26%
View Source
Ben Hendrix
RBC Capital
Price Target 478 USD
Upside/Downside 17%
View Source
David MacDonald
Truist Financial
Price Target 520 USD
Upside/Downside 27%
View Source
Sarah James
Raymond James
Price Target 485 USD
Upside/Downside 19%
View Source
Michael Ha
Robert W. Baird
Price Target 625 USD
Upside/Downside 53%
View Source
Ben Hendrix
RBC Capital
Price Target 585 USD
Upside/Downside 43%
View Source
David MacDonald
Truist Financial
Price Target 620 USD
Upside/Downside 52%
View Source
Erin Wright
Morgan Stanley
Price Target 643 USD
Upside/Downside 58%
View Source
Michael Ha
Robert W. Baird
Price Target 649 USD
Upside/Downside 59%
View Source
David Windley
Jefferies
Price Target 604 USD
Upside/Downside 48%
View Source
Stephen Baxter
Wells Fargo
Price Target 600 USD
Upside/Downside 47%
View Source
Ben Hendrix
RBC Capital
Price Target 575 USD
Upside/Downside 41%
View Source
Andrew Mok
Barclays
Price Target 621 USD
Upside/Downside 52%
View Source
AJ Rice
UBS
Price Target 605 USD
Upside/Downside 48%
View Source
Show More Price Targets
Show Less Price Targets
Elevance Health Inc Competitors:
Price Targets
ODPV3
Odontoprev SA
19% Upside
0HG8
Anthem Inc
37% Upside
CLOV
Clover Health Investments Corp
9% Downside
HAPV3
Hapvida Participacoes e Investimentos SA
99% Upside
UNH
UnitedHealth Group Inc
7% Upside
MOH
Molina Healthcare Inc
24% Upside
HUM
Humana Inc
5% Upside
HQY
Healthequity Inc
9% Upside

Revenue
Forecast

Revenue Estimate
Elevance Health Inc

For the last 8 years the compound annual growth rate for Elevance Health Inc's revenue is 10%. The projected CAGR for the next 3 years is 6%.

10%
Past Growth
6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Elevance Health Inc

For the last 8 years the compound annual growth rate for Elevance Health Inc's net income is 11%. The projected CAGR for the next 3 years is 17%.

11%
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ELV's stock price target?
Price Target
563.11 USD

According to Wall Street analysts, the average 1-year price target for ELV is 563.11 USD with a low forecast of 469.65 USD and a high forecast of 698.25 USD.

What is Elevance Health Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Elevance Health Inc's revenue is 10%. The projected CAGR for the next 3 years is 6%.

What is Elevance Health Inc's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Elevance Health Inc's net income is 11%. The projected CAGR for the next 3 years is 17%.

Back to Top